Do insurers see individual members' clinical data?

No. Insurers see aggregate, de-identified risk and outcomes. Individual readings are shared only with a provider the member has explicitly chosen.

How does this fit capitation or value-based contracts?

Under those models the party carrying risk benefits directly when members avoid escalation, so continuous monitoring becomes an investment rather than an expense.

What does it cost the member?

Nothing. The platform is free for individuals, which removes the usual barrier to adoption across a covered population.

Where is the data stored?

Rasd is built so health data can be hosted within the jurisdiction that governs it — designed around Saudi Arabia's Personal Data Protection Law from the outset.

For insurers and payers

Remote monitoring for health insurers

Insurers carry the cost of complications that were visible in the data long before they became claims. Continuous monitoring is the rare intervention whose incentives line up cleanly with a payer's.

Where the incentives align

A payer pays for what happens after a condition escalates. Prevention is therefore not a cost centre but a direct saving: a complication avoided is a claim that never arrives. That alignment is cleanest in chronic disease, where escalation is gradual, measurable and — with enough visibility — often reviewable while it is still routine.

Chronic disease is where the money is

The costs that dominate a chronic population are not the day-to-day management of the condition; they are the downstream events. Renal complications, cardiovascular events and unplanned admissions account for a disproportionate share of spend, and they develop over months in signals that are already being measured by devices members own. Following those signals is comparatively inexpensive.

Built for value-based and capitation models

As payment shifts from fee-for-service toward outcomes and capitation, the party carrying the risk gains a direct interest in members staying well. Saudi Arabia's move toward value-based payment by 2027 makes this concrete: prevention starts to fund itself. Rasd is designed for that model rather than for volume.

What an insurer actually sees

Insurers see aggregate, de-identified risk across a population — distribution of risk levels, the conditions most frequently flagged, and how cohorts move over time. They do not receive raw clinical records. Individual data reaches a provider only where the member has explicitly consented to share it.

Starting with a defined cohort

The practical way to begin is narrow: one chronic cohort, a defined period, and an agreed measure of what success looks like. Diabetes is the usual starting point because the devices are already in members' hands and the downstream costs are well understood.

Why payers are the natural first customer

Every complication prevented is a claim avoided
Chronic escalation is gradual, measurable and often reviewable early
Aligned with value-based and capitation payment models
Population view is aggregate and de-identified by design
Members join free, so adoption is not a cost to the payer

Common questions

Do insurers see individual members' clinical data?: No. Insurers see aggregate, de-identified risk and outcomes. Individual readings are shared only with a provider the member has explicitly chosen.
How does this fit capitation or value-based contracts?: Under those models the party carrying risk benefits directly when members avoid escalation, so continuous monitoring becomes an investment rather than an expense.
What does it cost the member?: Nothing. The platform is free for individuals, which removes the usual barrier to adoption across a covered population.
Where is the data stored?: Rasd is built so health data can be hosted within the jurisdiction that governs it — designed around Saudi Arabia's Personal Data Protection Law from the outset.

Model this against your own population

Tell us about your covered population and our team will walk through where continuous monitoring would apply.

Request a demo

Rasd provides health awareness and guidance only. It does not diagnose, treat, or replace professional medical advice. Always consult a qualified healthcare provider.